MedPath
HSA Approval

GLYBORAL TABLET 5 mg

SIN11789P

GLYBORAL TABLET 5 mg

GLYBORAL TABLET 5 mg

January 26, 2002

ZYFAS MEDICAL CO

ZYFAS MEDICAL CO

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS MEDICAL CO
Licence HolderZYFAS MEDICAL CO

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A10BB01

glibenclamide

Manufacturer Information

ZYFAS MEDICAL CO

USV LIMITED

Active Ingredients

GLIBENCLAMIDE

5 mg

Glyburide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLYBORAL TABLET 5 mg - HSA Approval | MedPath